BR0213861A - Processo para a preparação de composições de ribavirina de carga elevada, de dissolução rápida - Google Patents

Processo para a preparação de composições de ribavirina de carga elevada, de dissolução rápida

Info

Publication number
BR0213861A
BR0213861A BR0213861-1A BR0213861A BR0213861A BR 0213861 A BR0213861 A BR 0213861A BR 0213861 A BR0213861 A BR 0213861A BR 0213861 A BR0213861 A BR 0213861A
Authority
BR
Brazil
Prior art keywords
ribavirin
composition
compositions
granulation
preparation
Prior art date
Application number
BR0213861-1A
Other languages
English (en)
Inventor
Amol Singh Matharu
Mahendra R Patel
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of BR0213861A publication Critical patent/BR0213861A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)

Abstract

"PROCESSO PARA A PREPARAçãO DE COMPOSIçõES DE RIBAVIRINA DE CARGA ELEVADA, DE DISSOLUçãO RáPIDA". A presente invenção refere-se a uma composição de ribavirina de carga elevada, de dissolução rápida a qual é essencialmente livre de formas polimórficas de ribavirina, a referida composição é preparada por um processo compreendendo: (a) misturar ribavirina, pelo menos um desintegrante e /ou pelo menos uma carga para formar uma mistura homogênea; (b) granular a mistura na presença de água para formar uma granulação; (c) secar a granulação; e (d) misturar pelo menos um desintegrante e /ou pelo menos um lubrificante com a granulação para produzir uma composição de ribavirina, onde a referida composição de ribavirina compreende pelo menos 80 por cento em peso de ribavirina, com base no peso total da composição. As composições de ribavirina preparadas pelo processo de granulação úmida da invenção são de fluxo livre e têm adequada densidade de carga para processamento em cápsulas. Além disso, as composições de ribavirina contêm pelo menos 80 por cento em peso de ribavirina. Além disso, as composições de ribavirina são substancialmente livres de formas polimórficas de ribavirina, isto é, não existe nenhum sinal de alteração polimórfica na ribavirina tal como determinado pela espectrofotometria de infravermelho.
BR0213861-1A 2001-11-02 2002-10-31 Processo para a preparação de composições de ribavirina de carga elevada, de dissolução rápida BR0213861A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33685301P 2001-11-02 2001-11-02
PCT/US2002/034899 WO2003039517A1 (en) 2001-11-02 2002-10-31 Process for preparing quick dissolving, high loading ribavirin compositions

Publications (1)

Publication Number Publication Date
BR0213861A true BR0213861A (pt) 2004-12-21

Family

ID=23317956

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0213861-1A BR0213861A (pt) 2001-11-02 2002-10-31 Processo para a preparação de composições de ribavirina de carga elevada, de dissolução rápida

Country Status (16)

Country Link
US (1) US20030104050A1 (pt)
EP (1) EP1443911A1 (pt)
JP (1) JP2005511587A (pt)
KR (1) KR20050042035A (pt)
CN (1) CN1585631A (pt)
AU (1) AU2002350082B9 (pt)
BR (1) BR0213861A (pt)
CA (1) CA2465159A1 (pt)
HR (1) HRP20040384A2 (pt)
HU (1) HUP0402364A2 (pt)
IL (1) IL161697A0 (pt)
MX (1) MXPA04004181A (pt)
NO (1) NO20042143L (pt)
PL (1) PL368550A1 (pt)
RU (1) RU2004116821A (pt)
WO (1) WO2003039517A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720000B2 (en) * 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets
US7538094B2 (en) 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
CZ298224B6 (cs) * 2003-04-29 2007-07-25 Pliva Istrazivanje I Razvoj D.O.O. Farmaceutická kompozice obsahující jako úcinnou látku ribavirin a zpusob její výroby
NZ551536A (en) * 2004-05-24 2010-10-29 Nycomed Pharma As Particulate comprising a calcium-containing compound and a sugar alcohol
WO2006002365A2 (en) * 2004-06-24 2006-01-05 Angiotech International Ag Microparticles with high loadings of a bioactive agent
US7723310B2 (en) * 2004-10-18 2010-05-25 Three Rivers Pharmaceuticals, Llc Large dose ribavirin formulations
US20060110479A1 (en) * 2004-11-24 2006-05-25 Mitra Shankar K Natural composition for curing hepatitis-B, methods for making the same and pharmaceutical formulations thereof
US8263137B2 (en) 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US7901710B2 (en) 2005-08-04 2011-03-08 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8202546B2 (en) * 2005-08-04 2012-06-19 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
WO2008079343A2 (en) * 2006-12-21 2008-07-03 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
US8202996B2 (en) * 2007-12-21 2012-06-19 Bristol-Myers Squibb Company Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N- ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide
WO2010062996A2 (en) * 2008-11-28 2010-06-03 Adamas Pharmaceuticals, Inc. Ribavirin composition
EP2295037A1 (en) 2009-09-11 2011-03-16 Ratiopharm GmbH Pharmaceutical formulation containing Ribavirin
WO2011154772A1 (es) * 2010-06-08 2011-12-15 Laboratorio De Diagnostico Gam, S.A. Composición veterinaria oral para salmónidos que comprende 1-beta-d-ribofuranosil-1h-1,2,4-triazol-3-carboxamida y el uso para el tratamiento de la anemia infecciosa del salmón (isa) en salmónidos
CN107847608A (zh) * 2015-06-09 2018-03-27 联邦科学和工业研究组织 聚阴离子聚合物和抗病毒药物的抗病毒共轭物
CN106806345B (zh) * 2015-11-27 2020-10-13 北京科信必成医药科技发展有限公司 一种利巴韦林掩味颗粒及其制备方法
CN108464972A (zh) * 2018-07-02 2018-08-31 福州大学 一种含有斯诺普利的抗肺动脉高压口服片剂及其制备方法
AU2021357705A1 (en) 2020-10-05 2023-05-18 XWPharma Ltd. Modified release compositions of a gamma-hydroxybutyric acid derivative
CN113304114B (zh) * 2021-06-08 2022-06-10 药大制药有限公司 一种利巴韦林颗粒及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3277520A (en) * 1963-06-18 1966-10-11 Fuji Denki Kogyo Kabushiki Kai Method and apparatus for making spherical granules
US3927216A (en) * 1971-06-01 1975-12-16 Icn Pharmaceuticals 1,2,4-Triazol E-3-carboxamides for inhibiting virus infections
US3798209A (en) * 1971-06-01 1974-03-19 Icn Pharmaceuticals 1,2,4-triazole nucleosides
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
US3976545A (en) * 1973-03-12 1976-08-24 Icn Pharmaceuticals, Inc. 1,2,4-Triazol E-3-carboxamides as antiviral agents
US3948885A (en) * 1973-03-19 1976-04-06 Icn Pharmaceuticals, Inc. 5-Hydroxyl-1,2,3-triazole-4-carboxamide nucleoside
US4138547A (en) * 1977-12-22 1979-02-06 Icn Pharmaceuticals, Inc. Process for preparing 1,2,4-triazole nucleosides
US4439453A (en) * 1980-12-22 1984-03-27 Monsanto Company Directly compressible acetaminophen granulation
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
US5405837A (en) * 1993-05-18 1995-04-11 Indiana University Foundation Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin
ES2214551T3 (es) * 1995-11-02 2004-09-16 Schering Corporation Terapia de infusion continua de citocinas a baja dosis.
US5908621A (en) * 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
US5767097A (en) * 1996-01-23 1998-06-16 Icn Pharmaceuticals, Inc. Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
US6150337A (en) * 1996-01-23 2000-11-21 Icn Pharmaceuticals, Inc. Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes
SK284054B6 (sk) * 1996-10-16 2004-08-03 Icn Pharmaceuticals, Inc. Substituované triazolové nukleozidy, farmaceutický prostriedok s ich obsahom a ich použitie
US6172046B1 (en) * 1997-09-21 2001-01-09 Schering Corporation Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection
US6472373B1 (en) * 1997-09-21 2002-10-29 Schering Corporation Combination therapy for eradicating detectable HCV-RNA in antiviral treatment naive patients having chronic hepatitis C infection
US5916594A (en) * 1997-12-22 1999-06-29 Schering Corporation Process of making solid ribavirin dosage forms
US5914128A (en) * 1997-12-22 1999-06-22 Schering Corporation Orally administrable solid dosage form
EP1321147A1 (en) * 1997-12-22 2003-06-25 Schering Corporation Orally administrable solid ribavirin dosage forms and process for making them
US20030104048A1 (en) * 1999-02-26 2003-06-05 Lipocine, Inc. Pharmaceutical dosage forms for highly hydrophilic materials
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US6720000B2 (en) * 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets

Also Published As

Publication number Publication date
PL368550A1 (en) 2005-04-04
AU2002350082B9 (en) 2006-08-31
IL161697A0 (en) 2004-09-27
CN1585631A (zh) 2005-02-23
MXPA04004181A (es) 2005-01-25
CA2465159A1 (en) 2003-05-15
US20030104050A1 (en) 2003-06-05
JP2005511587A (ja) 2005-04-28
KR20050042035A (ko) 2005-05-04
EP1443911A1 (en) 2004-08-11
RU2004116821A (ru) 2005-04-20
NO20042143L (no) 2004-05-25
AU2002350082B2 (en) 2006-07-20
HUP0402364A2 (hu) 2005-02-28
HRP20040384A2 (en) 2005-08-31
WO2003039517A1 (en) 2003-05-15

Similar Documents

Publication Publication Date Title
BR0213861A (pt) Processo para a preparação de composições de ribavirina de carga elevada, de dissolução rápida
BR9916097A (pt) Dispersões de polìmeros terminados em silila com elevado teor de sólidos, sua preparação e aplicação
BR0317392A (pt) Formulação não-higroscópica incluindo uma droga higroscópica
BR0308231A (pt) Composições farmacêuticas em grânulos de liberação imediata e um processo contìnuo para a obtenção das mesmas
BRPI0408681A (pt) compostos, composições farmacêuticas, uso de um derivado da 1,2,3,4-tetraidroisoquinolina, método para tratar ou prevenir doenças, processo para a manufatura de composições farmacêuticas, e, uso de um ou mais compostos
BRPI0514922A (pt) processo para a produção de um material básico revestido para uma composição hidráulica, material básico revestido para uma composição hidráulica, aditivo para uma composição hidráulica e processo para a produção de uma composição hidráulica
BRPI0312398B8 (pt) derivado de 1,3-difenilprop-2-en-1-ona substituído, processo de preparação de compostos, composição farmacêutica e utilização de pelo menos um derivado de 1,3-difenilprop-2-en-1-ona substituído
BRPI0509665A (pt) composição detergente com ingredientes coloridos mascarados
BR9914932A (pt) Processo para a manufatura de uma composição de isotretinoìna, composição de isotretinoìna micronizada, forma de dosagem unitária para administração enteral e composição farmacêutica na forma de dosagem unitária
BR0211736A (pt) Formulação para suspensão oral estabilizada
BR0103844A (pt) Sistema de aditivo polimérico múltiplo, processo para produzir o mesmo, composição polimérica, e, processo para produzir a mesma
BR0306143A (pt) Grânulos ou pó para a produção de agentes de revestimento e aglutinantes para formas farmacêuticas
BR0208973A (pt) Composição alimentìcia de animal de estimação contendo agente de formação de gel semi-refinado
BRPI0510408A (pt) composições autovaporizantes, artigos compreendendo essas composições e métodos para preparo das mesmas
BR9915491A (pt) Composição detergente particulada de lavagem de roupas e de livre escoamento, processo para a preparação de um componente detergente granular de livre escoamento, e, componente detergente granular e de livre escoamento
BR9916941A (pt) Composições detergentes para lavagem de louçacontendo tensoativos de cristalinidade rompida
BR0207919A (pt) Método para a preparação de uma micropartìcula homogênea de metoprolol, micropartìcula, composição farmacêutica, método para prevenir ou tratar um distúrbio cardiovascular em um mamìfero, e, uso de uma micropartìcula
BR112022003443A2 (pt) Processo de preparação de composição de mistura asfáltica, composição de mistura asfáltica, uso de uma composição de mistura asfáltica
BR9915156A (pt) Composições de resinas termoplásticas, processo para produção de composição de resina termoplástica, e, mistura de cargas para uso em composições de resina termoplástica.
BR0213561A (pt) Processo para a preparação de amidas de ácido 2-halopiridincarboxìlico
BR0101492A (pt) Misturas de pelo menos um enchedor e compostosde organossilìcio, processo para sua preparação eseu uso
BR0209472A (pt) Composição detergente particulada para lavagem de roupa
BR0213432A (pt) Processo para a preparação de grânulos de detergente
BR9914441A (pt) Composição de alta pureza compreendendo (7-alfa, 17-alfa) - 17-hidroxi-7-metil-19-nor-17-pregn- 5(10)-en-20-in-3-ona, processo para preparar as composições de alta pureza, e, unidade de dosagem farmacêutica
BRPI0415936A (pt) composição estabilizada de azitromicina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2099 DE 29/03/2011.